nitrates has been researched along with Nervous System Diseases in 14 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study examined effects of inorganic magnesium agents: magnesium nitrate Mg(NO3)2, magnesium sulfate MgSO4, and magnesium chloride MgCl2 on the development of neurological disorders and mortality in rats resulting from cerebral ischemia provoked by a single-stage bilateral occlusion of the common carotid arteries." | 7.80 | Protective effect of magnesium nitrate against neurological disorders provoked by cerebral ischemia in rats. ( Krushinskii, AL; Kuzenkov, VS, 2014) |
| "The study examined effects of inorganic magnesium agents: magnesium nitrate Mg(NO3)2, magnesium sulfate MgSO4, and magnesium chloride MgCl2 on the development of neurological disorders and mortality in rats resulting from cerebral ischemia provoked by a single-stage bilateral occlusion of the common carotid arteries." | 3.80 | Protective effect of magnesium nitrate against neurological disorders provoked by cerebral ischemia in rats. ( Krushinskii, AL; Kuzenkov, VS, 2014) |
| "To investigate whether nitric oxide (NO) plays a role in degenerative neurologic disease (DND), we measured nitrite, nitrate and cyclic GMP in cerebrospinal fluid (CSF) samples from patients with Parkinson's disease (PD), spinocerebellar ataxia (SCA) and amyotrophic lateral sclerosis (ALS)." | 3.69 | Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases. ( Ikeda, M; Miyatake, T; Murota, S; Sato, I; Yuasa, T, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuzenkov, VS | 1 |
| Krushinskii, AL | 1 |
| Abdel Baky, NA | 1 |
| Zaidi, ZF | 1 |
| Fatani, AJ | 1 |
| Sayed-Ahmed, MM | 1 |
| Yaqub, H | 1 |
| Shirhan, MD | 1 |
| Moochhala, SM | 1 |
| Ng, PY | 1 |
| Lu, J | 1 |
| Ng, KC | 1 |
| Teo, AL | 1 |
| Yap, E | 1 |
| Ng, I | 1 |
| Hwang, P | 1 |
| Lim, T | 1 |
| Sitoh, YY | 1 |
| Rumpel, H | 1 |
| Jose, R | 1 |
| Ling, E | 1 |
| Ramirez, J | 1 |
| Garnica, R | 1 |
| Boll, MC | 1 |
| Montes, S | 1 |
| Rios, C | 1 |
| Xia, CF | 1 |
| Smith, RS | 1 |
| Shen, B | 1 |
| Yang, ZR | 1 |
| Borlongan, CV | 1 |
| Chao, L | 1 |
| Chao, J | 1 |
| Milstien, S | 1 |
| Sakai, N | 1 |
| Brew, BJ | 1 |
| Krieger, C | 1 |
| Vickers, JH | 1 |
| Saito, K | 1 |
| Heyes, MP | 1 |
| Kuiper, MA | 1 |
| Visser, JJ | 1 |
| Bergmans, PL | 1 |
| Scheltens, P | 1 |
| Wolters, EC | 1 |
| Ikeda, M | 1 |
| Sato, I | 1 |
| Yuasa, T | 1 |
| Miyatake, T | 1 |
| Murota, S | 1 |
| Lipton, SA | 1 |
| Giovannoni, G | 2 |
| Heales, SJ | 3 |
| Silver, NC | 1 |
| O'Riordan, J | 1 |
| Miller, RF | 2 |
| Land, JM | 3 |
| Clark, JB | 2 |
| Thompson, EJ | 2 |
| Harrison, MJ | 1 |
| Cross, AH | 1 |
| Manning, PT | 1 |
| Keeling, RM | 1 |
| Schmidt, RE | 1 |
| Misko, TP | 1 |
| Bolaños, JP | 1 |
| Stewart, VC | 1 |
| Brookes, PS | 1 |
| Drulović, J | 1 |
| Dujmović, I | 1 |
| Mesaros, S | 1 |
| Samardzić, T | 1 |
| Maksimović, D | 1 |
| Stojsavljević, N | 1 |
| Lević, Z | 1 |
| Mostarica Stojokvić, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship[NCT02806128] | 100 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for nitrates and Nervous System Diseases
| Article | Year |
|---|---|
Distinctive chemistries of no-related species.
Topics: Animals; Humans; Nervous System Diseases; Nitrates; Nitric Oxide; Receptors, N-Methyl-D-Aspartate; S | 1996 |
Nitric oxide, mitochondria and neurological disease.
Topics: Amyotrophic Lateral Sclerosis; Astrocytes; Cell Death; Electron Transport; Glutamic Acid; Humans; Mi | 1999 |
12 other studies available for nitrates and Nervous System Diseases
| Article | Year |
|---|---|
Protective effect of magnesium nitrate against neurological disorders provoked by cerebral ischemia in rats.
Topics: Animals; Brain Ischemia; Carotid Artery, Common; Ligation; Magnesium Chloride; Magnesium Compounds; | 2014 |
Nitric oxide pros and cons: The role of L-arginine, a nitric oxide precursor, and idebenone, a coenzyme-Q analogue in ameliorating cerebral hypoxia in rat.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Arginine; Brain; Catalase; Creatine Kinase; Disease M | 2010 |
Spermine reduces infarction and neurological deficit following a rat model of middle cerebral artery occlusion: a magnetic resonance imaging study.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Chemistry; Brain Infarction; Brain Mapping; D | 2004 |
Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study.
Topics: Adult; Brain; Female; Headache; Humans; Male; Nervous System Diseases; Nitrates; Nitric Oxide; Nitri | 2004 |
Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Cerebral Infarction; Female; Glycogen Synthase Kinase 3; | 2006 |
Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Biopterins; HIV Infections; Humans; Hunti | 1994 |
Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients.
Topics: Aged; Alzheimer Disease; Atrophy; Dementia; Female; Humans; Male; Middle Aged; Nerve Degeneration; N | 1994 |
Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases.
Topics: Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Cyclic GMP; Female; Humans; Male; Middle Aged; Nerv | 1995 |
Raised serum nitrate and nitrite levels in patients with multiple sclerosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV-1; Humans; Male; Middle Aged; Multiple Sclero | 1997 |
Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction.
Topics: Acquired Immunodeficiency Syndrome; Adult; Blood-Brain Barrier; Female; HIV-1; Humans; Male; Middle | 1998 |
Peroxynitrite formation within the central nervous system in active multiple sclerosis.
Topics: Central Nervous System; Humans; Immunohistochemistry; Inflammation; Multiple Sclerosis; Nervous Syst | 1998 |
Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Brain Neoplasms; Female; Humans; Magnetic Resonance Im | 2001 |